Rubric Capital Management (New York)’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,000,000
| Closed | -$3.05M | – | 107 |
|
|
2022
Q4 | $3.05M | Hold |
7,000,000
| – | – | 0.13% | 81 |
|
|
2022
Q3 | $1.96M | Buy |
7,000,000
+988,995
| +16% | +$277K | 0.1% | 78 |
|
|
2022
Q2 | $2.17M | Buy |
6,011,005
+3,011,005
| +100% | +$1.08M | 0.11% | 78 |
|
|
2022
Q1 | $2.01M | Hold |
3,000,000
| – | – | 0.07% | 69 |
|
|
2021
Q4 | $3.87M | Hold |
3,000,000
| – | – | 0.18% | 57 |
|
|
2021
Q3 | $6.51M | Hold |
3,000,000
| – | – | 0.18% | 45 |
|
|
2021
Q2 | $8.19M | Buy |
3,000,000
+499,582
| +20% | +$1.36M | 0.52% | 42 |
|
|
2021
Q1 | $6.53M | Buy |
2,500,418
+165,218
| +7% | +$431K | 0.38% | 50 |
|
|
2020
Q4 | $6.49M | Buy |
2,335,200
+1,875,000
| +407% | +$5.21M | 0.48% | 46 |
|
|
2020
Q3 | $2.13M | Hold |
460,200
| – | – | 0.2% | 58 |
|
|
2020
Q2 | $1.3M | Hold |
460,200
| – | – | 0.15% | 49 |
|
|
2020
Q1 | $1.12M | Buy |
+460,200
| New | +$1.12M | 0.18% | 47 |
|